LYVE1 antibody (AA 271-275)
Quick Overview for LYVE1 antibody (AA 271-275) (ABIN5689389)
Target
See all LYVE1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 271-275
-
Specificity
- This antibody detects endogenous level of total Lymphatic vessel endothelial hyaluronic acid receptor 1 protein.
-
Purification
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogen
- Lymphatic vessel endothelial hyaluronic acid receptor 1 antibody was raised against a peptide sequence around aa.271~275 (K-N-Q-Q-K) derived from Human Lymphatic vessel endothelial hyaluronic acid receptor 1.
-
-
-
-
Application Notes
- Western Blot: 1:500~1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store antibody at -20°C for up to one year.
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Alternative Name
- Lymphatic vessel endothelial hyaluronic acid receptor 1
-
Background
- Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as an hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.
-
Molecular Weight
- 40 kDa
-
Gene ID
- 10894
-
NCBI Accession
- NP_006682
-
UniProt
- Q9Y5Y7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-